Literature DB >> 18838167

Drug-induced hypersensitivity syndrome after bortezomib treatment for refractory multiple myeloma.

Norimichi Hattori, Daisuke Adachi, Hidetoshi Nakashima, Bungo Saito, Tsuyoshi Nakamaki, Shigeru Tomoyasu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18838167     DOI： 10.1016/j.leukres.2008.08.023

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  3 in total

Review 1.  Characterizing DRESS syndrome recurrence: a systematic review.

Authors:  Ajay N Sharma; Samantha Shwe; Vignesh Ravi; Melanie Miller; Natasha A Mesinkovska; Nathan W Rojek; Scott Worswick
Journal:  Arch Dermatol Res       Date:  2021-09-10       Impact factor: 3.033

Review 2.  Severe cutaneous adverse reactions induced by targeted anticancer therapies and immunotherapies.

Authors:  Chun-Bing Chen; Ming-Ying Wu; Chau Yee Ng; Chun-Wei Lu; Jennifer Wu; Pei-Han Kao; Chan-Keng Yang; Meng-Ting Peng; Chen-Yang Huang; Wen-Cheng Chang; Rosaline Chung-Yee Hui; Chih-Hsun Yang; Shun-Fa Yang; Wen-Hung Chung; Shih-Chi Su
Journal:  Cancer Manag Res       Date:  2018-05-17       Impact factor: 3.989

3.  Recurrent Drug-Induced Hypersensitivity Syndrome Following Bortezomib for Multiple Myeloma.

Authors:  Austin B Ambur; Rajiv Nathoo
Journal:  Cureus       Date:  2021-12-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.